David A. Robins

Biography

David Robins has been instrumental in expanding DavosPharma from strictly manufacturing and marketing of small molecule building blocks for active substances to a full service provider. Under his leadership, DavosPharma now supports all manufacturing, biology and regulatory needs for commercial and IND drug development. Prior to joining Davos, Mr. Robins was a lead Process Engineer at Bristol-Myers Squibb where he was responsible for the scale up and tech transfer of several late stage and commercial drugs. Mr. Robins received his B.S. in Engineering Chemistry from Queen’s University in Kingston, Ontario and M.S. in Chemical Engineering from Syracuse University. Brian Robins joined DavosPharma in 1994. He focused on a number of multinational and emerging pharmaceutical companies, developing six clinical candidates. Two of these NCE projects are in late Phase III clinical trials, and one is awaiting FDA approval Prior to joining DavosPharma, Mr. Robins worked at Delmar Chemical in Montreal. Mr. Robins holds a B.Sc. in Chemical Engineering from Queen's University, Kingston, Ontario

Research Interest

clinical trials